Back

Macrophages induce inflammation by efferocytosis of apoptotic prostate cancer cells via HIF-1α stabilization

Mendoza-Reinoso, V.; Schnepp, P. M.; Baek, D. Y.; Rubin, J. R.; Schipani, E.; Keller, E. T.; McCauley, L. K.; Roca, H.

2021-09-02 cancer biology
10.1101/2021.09.02.458687 bioRxiv
Show abstract

Clearance of apoptotic cancer cells by macrophages, known as efferocytosis, fuels the bone-metastatic growth of prostate cancer cells via pro-inflammatory and immunosuppressive processes. However, the exact molecular mechanisms remain unclear. In this study, single-cell transcriptomics of bone marrow macrophages undergoing efferocytosis of apoptotic prostate cancer cells revealed a significant enrichment of a cellular response to hypoxia. Here we show that efferocytic macrophages promote HIF-1 stabilization under normoxic conditions through interaction with phosphorylated STAT3. Inflammatory cytokine gene expression analysis of efferocytic HIF-1-mutant macrophages revealed a reduced expression of the pro-tumorigenic Mif. Furthermore, stabilization of HIF-1 using the HIF-prolyl-hydroxylase inhibitor, Roxadustat, enhanced MIF expression in macrophages. Finally, macrophages treated with recombinant MIF protein activated NF-{kappa}B (p65) signaling and increased the expression of pro-inflammatory cytokines. Altogether, these findings suggest that the clearance of apoptotic cancer cells by tumor-associated macrophages triggers p-STAT3/HIF-1/MIF signaling to enhance tumor-promoting inflammation in bone, suggesting this axis as a target for metastatic prostate cancer.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Oncogene
76 papers in training set
Top 0.1%
22.5%
2
Cell Death & Disease
126 papers in training set
Top 0.1%
14.3%
3
Nature Communications
4913 papers in training set
Top 23%
8.2%
4
Cancer Research
116 papers in training set
Top 0.2%
6.8%
50% of probability mass above
5
eLife
5422 papers in training set
Top 13%
6.4%
6
Cell Reports
1338 papers in training set
Top 7%
6.3%
7
Molecular Cancer Research
42 papers in training set
Top 0.2%
1.9%
8
Clinical Cancer Research
58 papers in training set
Top 1.0%
1.7%
9
Advanced Science
249 papers in training set
Top 11%
1.7%
10
Molecular Oncology
50 papers in training set
Top 0.4%
1.7%
11
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
12
iScience
1063 papers in training set
Top 18%
1.5%
13
JCI Insight
241 papers in training set
Top 4%
1.3%
14
EMBO reports
136 papers in training set
Top 4%
1.1%
15
Cancer Letters
32 papers in training set
Top 0.6%
0.9%
16
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.2%
0.9%
17
JBMR Plus
16 papers in training set
Top 0.3%
0.8%
18
Cell Death Discovery
51 papers in training set
Top 1%
0.8%
19
Scientific Reports
3102 papers in training set
Top 73%
0.8%
20
International Journal of Cancer
42 papers in training set
Top 1%
0.8%
21
Cancers
200 papers in training set
Top 5%
0.7%
22
Journal of Bone and Mineral Research
32 papers in training set
Top 0.4%
0.7%
23
PLOS Biology
408 papers in training set
Top 20%
0.7%
24
Science Advances
1098 papers in training set
Top 31%
0.7%
25
Theranostics
33 papers in training set
Top 2%
0.7%
26
EMBO Reports
88 papers in training set
Top 0.8%
0.7%
27
Developmental Cell
168 papers in training set
Top 13%
0.6%
28
Oncogenesis
12 papers in training set
Top 0.3%
0.6%